Can Coronary Artery Disease Cause Valvular Regurgitation?
Coronary artery disease (CAD) can directly cause mitral and tricuspid regurgitation through ischemic mechanisms, but does not directly cause aortic or pulmonic regurgitation.
Mitral Regurgitation and CAD
CAD is a well-established cause of secondary (functional) mitral regurgitation through ischemic mechanisms 1, 2, 3. The pathophysiology involves:
- Papillary muscle dysfunction or rupture from myocardial infarction
- Left ventricular remodeling with wall motion abnormalities causing leaflet tethering
- Annular dilation secondary to LV dysfunction
- Restricted leaflet motion due to altered ventricular geometry
2 specifically addresses ischemic mitral regurgitation (IMR) as a common manifestation in patients with CAD, noting that the severity of IMR exerts a graded effect on survival—the greater the degree of IMR, the lower the survival. The mechanism is functional rather than structural valve disease, with the valve leaflets themselves being structurally normal 4, 3.
Clinical significance: Patients with CAD and reduced LV function commonly develop concomitant secondary mitral regurgitation 1. When moderate-to-severe MR accompanies CAD requiring revascularization, mitral valve repair should be considered during CABG, particularly with LVEF ≤35% 1, 5.
Tricuspid Regurgitation and CAD
CAD can cause functional tricuspid regurgitation through indirect mechanisms 6, 7:
- Right ventricular dysfunction secondary to RV infarction
- Pulmonary hypertension from left heart failure due to CAD
- Tricuspid annular dilation from RV volume/pressure overload
- RV remodeling in the setting of ischemic cardiomyopathy
6 documents cases of severe isolated tricuspid insufficiency in the setting of severe coronary disease with preserved left ventricular function, demonstrating that CAD can directly affect the right heart. 7 notes that TR is common in patients with ischemic mitral regurgitation, often developing as a consequence of the hemodynamic burden from left-sided disease.
Important caveat: Most TR in CAD patients is secondary and functional rather than organic valve disease. The tricuspid valve leaflets remain structurally normal, but regurgitation occurs due to annular dilation and altered RV geometry 4, 8.
Aortic Regurgitation and CAD
CAD does NOT directly cause aortic regurgitation. There is no mechanistic pathway by which coronary artery disease affects the aortic valve structure or function. The evidence provided contains no references linking CAD to AR 4, 1, 8, 9.
Aortic regurgitation results from:
- Aortic valve leaflet abnormalities (bicuspid valve, degenerative disease)
- Aortic root/ascending aorta pathology (dilation, dissection)
- Endocarditis
- Rheumatic disease
While patients with CAD may coincidentally have AR, this represents coexisting disease rather than a causal relationship.
Pulmonic Regurgitation and CAD
CAD does NOT directly cause pulmonic regurgitation. Similar to AR, there is no pathophysiologic mechanism linking coronary disease to pulmonic valve dysfunction 8, 9.
Pulmonic regurgitation typically results from:
- Pulmonary hypertension (causing annular dilation)
- Congenital heart disease (especially post-repair tetralogy of Fallot)
- Endocarditis
- Carcinoid syndrome
Exception: Severe pulmonary hypertension secondary to left heart failure from CAD could theoretically cause functional PR through annular dilation, but this would be an indirect effect through elevated pulmonary pressures rather than direct coronary disease.
Clinical Algorithm for Assessment
When evaluating valvular regurgitation in CAD patients:
Mitral regurgitation: Assume ischemic/functional etiology until proven otherwise
- Assess LV function, wall motion abnormalities, and leaflet tethering
- Coronary angiography is recommended before valve surgery 1
- Consider revascularization impact on MR severity
Tricuspid regurgitation: Determine if secondary to RV dysfunction or pulmonary hypertension from left heart disease
- Evaluate RV size/function and pulmonary pressures
- Assess for RV infarction if acute presentation
Aortic/pulmonic regurgitation: Search for alternative etiologies
- These are NOT caused by CAD
- Evaluate valve morphology and aortic/pulmonary artery dimensions
- Consider separate pathologic processes
Critical pitfall: Do not attribute all valvular disease in CAD patients to ischemia. Only mitral and tricuspid regurgitation have established ischemic mechanisms. Aortic and pulmonic regurgitation require separate diagnostic evaluation 4, 1, 8.